CoChat
Sign Up
Cited by 190

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

IL-33 and IL-33 Receptors in Host Defense and Diseases

Oboki, Keisuke, Ohno, Tatsukuni, Kajiwara, Naoki, Saito, Hirohisa, Nakae, Susumu·2010·Allergology International
DOI 10.2332/allergolint.10-rai-0186
Open this paper in CoChat — free account

Abstract

Interleukin-33 (IL-33) is a member of the IL-1 cytokine family, which includes IL-1 and IL-18. IL-33 is considered to be crucial for induction of Th2-type cytokine-associated immune responses such as host defense against nematodes and allergic diseases by inducing production of such Th2-type cytokines as IL-5 and IL-13 by Th2 cells, mast cells, basophils and eosinophils. In addition, IL-33 is involved in the induction of non-Th2-type acute and chronic inflammation as a proinflammatory cytokine, similar to IL-1 and IL-18. In this review, we summarize and discuss the current knowledge regarding the roles of IL-33 and IL-33 receptors in host defense and disease development.

Overview

Integrity signals

Registry

Crossref · 10.2332/allergolint.10-rai-0186

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 9 references

Research works printed but not linked: 144

  1. Onda, 1999, Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage, J Cereb Blood Flow Metab, 19, 1279, 10.1097/00004647-199911000-00013 · DOI
  2. Baekkevold, 2003, Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules, Am J Pathol, 163, 69, 10.1016/S0002-9440(10)63631-0 · DOI
  3. Schmitz, 2005, IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, Immunity, 23, 479, 10.1016/j.immuni.2005.09.015 · DOI
  4. Ohno, 2009, Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages, J Immunol, 183, 7890, 10.4049/jimmunol.0802449 · DOI
  5. Roussel, 2008, Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket, EMBO Rep, 9, 1006, 10.1038/embor.2008.145 · DOI
  6. Chackerian, 2007, IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex, J Immunol, 179, 2551, 10.4049/jimmunol.179.4.2551 · DOI
  7. Ali, 2007, IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells, Proc Natl Acad Sci USA, 104, 18660, 10.1073/pnas.0705939104 · DOI
  8. O'Neill, 2008, The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress, Immunol Rev, 226, 10, 10.1111/j.1600-065X.2008.00701.x · DOI
  9. Arend, 2008, IL-1, IL-18, and IL-33 families of cytokines, Immunol Rev, 223, 20, 10.1111/j.1600-065X.2008.00624.x · DOI
  10. Iwahana, 1999, Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells, Eur J Biochem, 264, 397, 10.1046/j.1432-1327.1999.00615.x · DOI
  11. Tago, 2001, Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V, Biochem Biophys Res Commun, 285, 1377, 10.1006/bbrc.2001.5306 · DOI
  12. Iwahana, 2004, Molecular cloning of the chicken ST2 gene and a novel variant form of the ST2 gene product, ST2LV, Biochim Biophys Acta, 1681, 1, 10.1016/j.bbaexp.2004.08.013 · DOI
  13. Bulek, 2009, The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response, J Immunol, 182, 2601, 10.4049/jimmunol.0802729 · DOI
  14. Garlanda, 2009, TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization, Trends Immunol, 30, 439, 10.1016/j.it.2009.06.001 · DOI
  15. Garlanda, 2004, Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family, Proc Natl Acad Sci USA, 101, 3522, 10.1073/pnas.0308680101 · DOI
  16. Lecart, 2002, Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface, Eur J Immunol, 32, 2979, 10.1002/1521-4141(2002010)32:10<2979::AID-IMMU2979>3.0.CO;2-5 · DOI
  17. Lohning, 1998, T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function, Proc Natl Acad Sci USA, 95, 6930, 10.1073/pnas.95.12.6930 · DOI
  18. Nakae, 2007, Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17, J Leukoc Biol, 81, 1258, 10.1189/jlb.1006610 · DOI · Paper page
  19. Hoshino, 1999, The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function, J Exp Med, 190, 1541, 10.1084/jem.190.10.1541 · DOI
  20. Townsend, 2000, T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses, J Exp Med, 191, 1069, 10.1084/jem.191.6.1069 · DOI
  21. Kondo, 2008, Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system, Int Immunol, 20, 791, 10.1093/intimm/dxn037 · DOI
  22. Kurowska-Stolarska, 2008, IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4, J Immunol, 181, 4780, 10.4049/jimmunol.181.7.4780 · DOI
  23. Guo, 2009, IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells, Proc Natl Acad Sci USA, 106, 13463, 10.1073/pnas.0906988106 · DOI
  24. Pecaric-Petkovic, 2009, Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33, Blood, 113, 1526, 10.1182/blood-2008-05-157818 · DOI
  25. Smithgall, 2008, IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells, Int Immunol, 20, 1019, 10.1093/intimm/dxn060 · DOI
  26. Komai-Koma, 2007, IL-33 is a chemoattractant for human Th2 cells, Eur J Immunol, 37, 2779, 10.1002/eji.200737547 · DOI
  27. Kropf, 1999, Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection, Eur J Immunol, 29, 3621, 10.1002/(SICI)1521-4141(199911)29:11<3621::AID-IMMU3621>3.0.CO;2-Z · DOI
  28. Kropf, 2003, Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection, Infect Immun, 71, 1961, 10.1128/IAI.71.4.1961-1971.2003 · DOI
  29. Chan, 2001, Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes, J Immunol, 167, 1238, 10.4049/jimmunol.167.3.1238 · DOI
  30. McGuirk, 2002, Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis, J Exp Med, 195, 221, 10.1084/jem.20011288 · DOI
  31. Moritz, 1998, The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors, J Immunol, 161, 4866, 10.4049/jimmunol.161.9.4866 · DOI
  32. Chen, 2005, Identification of mast cell progenitors in adult mice, Proc Natl Acad Sci USA, 102, 11408, 10.1073/pnas.0504197102 · DOI · Paper page
  33. Iikura, 2007, IL-33 can promote survival, adhesion and cytokine production in human mast cells, Lab Invest, 87, 971, 10.1038/labinvest.3700663 · DOI
  34. Allakhverdi, 2007, Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells, J Immunol, 179, 2051, 10.4049/jimmunol.179.4.2051 · DOI · Paper page
  35. Ho, 2007, IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals, JLeukoc Biol, 82, 1481, 10.1189/jlb.0407200 · DOI
  36. Moulin, 2007, Interleukin (IL)-33 induces the release of proinflammatory mediators by mast cells, Cytokine, 40, 216, 10.1016/j.cyto.2007.09.013 · DOI
  37. Pushparaj, 2009, The cytokine interleukin-33 mediates anaphylactic shock, Proc Natl Acad Sci USA, 106, 9773, 10.1073/pnas.0901206106 · DOI
  38. Min, 2006, Basophils: a potential liaison between innate and adaptive immunity, Allergol Int, 55, 99, 10.2332/allergolint.55.99 · DOI
  39. Sullivan, 2009, Basophils: a nonredundant contributor to host immunity, Immunity, 30, 12, 10.1016/j.immuni.2008.12.006 · DOI
  40. Perrigoue, 2009, MHC class II-dependent basophil-CD4+ T cell interactions promote T (H)2 cytokine-dependent immunity, Nat Immunol, 10, 697, 10.1038/ni.1740 · DOI
  41. Sokol, 2009, Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response, Nat Immunol, 10, 713, 10.1038/ni.1738 · DOI
  42. Yoshimoto, 2009, Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells, Nat Immunol, 10, 706, 10.1038/ni.1737 · DOI
  43. Suzukawa, 2008, An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor, J Immunol, 181, 5981, 10.4049/jimmunol.181.9.5981 · DOI
  44. Schneider, 2009, IL-33 Activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production, J Immunol, 183, 3591, 10.4049/jimmunol.0900328 · DOI
  45. Kroeger, 2009, IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38 alpha-dependent pathway, J Leukoc Biol, 86, 769, 10.1189/jlb.0708452 · DOI
  46. Cherry, 2008, A novel IL-1 family cytokine, IL-33, potently activates human eosinophils, J Allergy Clin Immunol, 121, 1484, 10.1016/j.jaci.2008.04.005 · DOI
  47. Suzukawa, 2008, Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils, Lab Invest, 88, 1245, 10.1038/labinvest.2008.82 · DOI
  48. Bourgeois, 2009, The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production, Eur J Immunol, 39, 1046, 10.1002/eji.200838575 · DOI
  49. Mayuzumi, 2009, IL-33 promotes DC development in BM culture by triggering GMCSF production, Eur J Immunol, 39, 3331, 10.1002/eji.200939472 · DOI
  50. Rank, 2009, IL-33-activated dendritic cells induce an atypical TH2-type response, J Allergy Clin Immunol, 123, 1047, 10.1016/j.jaci.2009.02.026 · DOI
  51. Saenz, 2008, Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites, Immunol Rev, 226, 172, 10.1111/j.1600-065X.2008.00713.x · DOI
  52. Soumelis, 2002, Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP, Nat Immunol, 3, 673, 10.1038/ni805 · DOI
  53. Ito, 2005, TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand, J Exp Med, 202, 1213, 10.1084/jem.20051135 · DOI · Paper page
  54. Wang, 2007, IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells, J Exp Med, 204, 1837, 10.1084/jem.20070406 · DOI
  55. Omori, 2007, Induction of IL-4 expression in CD4 (+) T cells by thymic stromal lymphopoietin, J Immunol, 178, 1396, 10.4049/jimmunol.178.3.1396 · DOI
  56. Angkasekwinai, 2007, Interleukin 25 promotes the initiation of proallergic type 2 responses, J Exp Med, 204, 1509, 10.1084/jem.20061675 · DOI
  57. Sweet, 2001, A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression, J Immunol, 166, 6633, 10.4049/jimmunol.166.11.6633 · DOI
  58. Oshikawa, 2002, ST 2 protein induced by inflammatory stimuli can modulate acute lung inflammation, Biochem Biophys Res Commun, 299, 18, 10.1016/S0006-291X(02)02578-0 · DOI
  59. Kumar, 1997, Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli, Biochem Biophys Res Commun, 235, 474, 10.1006/bbrc.1997.6810 · DOI
  60. Saccani, 1998, Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo, Cytokine, 10, 773, 10.1006/cyto.1998.0359 · DOI
  61. Espinassous, 2009, IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex, J Immunol, 183, 1446, 10.4049/jimmunol.0803067 · DOI
  62. Xu, 1998, Selective expression of a stable cell surface molecule on type 2 but not type 1 helperTcells, J Exp Med, 187, 787, 10.1084/jem.187.5.787 · DOI
  63. Brint, 2004, ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance, Nat Immunol, 5, 373, 10.1038/ni1050 · DOI
  64. Glaccum, 1997, Phenotypic and functional characterization of mice that lack the type I receptor for IL-1, J Immunol, 159, 3364, 10.4049/jimmunol.159.7.3364 · DOI
  65. Hirsch, 1996, Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice, Proc Natl Acad Sci USA, 93, 11008, 10.1073/pnas.93.20.11008 · DOI
  66. Ma, 2003, Regulation of macrophage activation, Cell Mol Life Sci, 60, 2334, 10.1007/s00018-003-3020-0 · DOI
  67. Sica, 2008, Macrophage polarization in tumour progression, Semin Cancer Biol, 18, 349, 10.1016/j.semcancer.2008.03.004 · DOI · Paper page
  68. Kurowska-Stolarska, 2009, IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation, J Immunol, 183, 6469, 10.4049/jimmunol.0901575 · DOI
  69. Allakhverdi, 2009, CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation, J Allergy Clin Immunol, 123, 472, 10.1016/j.jaci.2008.10.022 · DOI · Paper page
  70. Moro, 2010, Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells, Nature, 463, 540, 10.1038/nature08636 · DOI
  71. Lotze, 2005, High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal, Nat Rev Immunol, 5, 331, 10.1038/nri1594 · DOI
  72. Cayrol, 2009, The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1, Proc Natl Acad Sci USA, 106, 9021, 10.1073/pnas.0812690106 · DOI · Paper page
  73. Talabot-Ayer, 2009, Interleukin-33 is biologically active independently of caspase-1 cleavage, J Biol Chem, 284, 19420, 10.1074/jbc.M901744200 · DOI
  74. Sacks, 2004, Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice, Immunol Rev, 201, 225, 10.1111/j.0105-2896.2004.00185.x · DOI
  75. Kropf, 2002, Organ-specific distribution of CD4+ T1/ST2+ Th2 cells in Leishmania major infection, Eur J Immunol, 32, 2450, 10.1002/1521-4141(200209)32:9<2450::AID-IMMU2450>3.0.CO;2-O · DOI
  76. Aliberti, 2004, Turning it on and off: regulation of dendritic cell function in Toxoplasma gondii infection, Immunol Rev, 201, 26, 10.1111/j.0105-2896.2004.00179.x · DOI
  77. Jones, 2010, IL-33 receptor (T 1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii, Eur J Immunol, 40, 426, 10.1002/eji.200939705 · DOI
  78. Finkelman, 2004, Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites, Immunol Rev, 201, 139, 10.1111/j.0105-2896.2004.00192.x · DOI · Paper page
  79. Senn, 2000, T1-deficient and T1-Fc-transgenic mice develop a normal protective Th2-type immune response following infection with Nippostrongylus brasiliensis, Eur J Immunol, 30, 1929, 10.1002/1521-4141(200007)30:7<1929::AID-IMMU1929>3.0.CO;2-1 · DOI
  80. Pearce, 2004, Th2 response polarization during infection with the helminth parasite Schistosoma mansoni, Immunol Rev, 201, 117, 10.1111/j.0105-2896.2004.00187.x · DOI
  81. Wynn, 2004, Immunopathogenesis of schistosomiasis, Immunol Rev, 201, 156, 10.1111/j.0105-2896.2004.00176.x · DOI
  82. Cliffe, 2004, The Trichuris muris system: a paradigm of resistance and susceptibility to intestinal nematode infection, Adv Parasitol, 57, 255, 10.1016/S0065-308X(04)57004-5 · DOI
  83. Humphreys, 2008, IL-33, a potent inducer of adaptive immunity to intestinal nematodes, J Immunol, 180, 2443, 10.4049/jimmunol.180.4.2443 · DOI
  84. Huang, 2007, ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis, Invest Ophthalmol Vis Sci, 48, 4626, 10.1167/iovs.07-0316 · DOI
  85. Hazlett, 2010, IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis, Invest Ophthalmol Vis Sci, 51, 1524, 10.1167/iovs.09-3983 · DOI
  86. Cooper, 2009, Cell-mediated immune responses in tuberculosis, Annu Rev Immunol, 27, 393, 10.1146/annurev.immunol.021908.132703 · DOI
  87. Wieland, 2009, ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis, Microbes Infect, 11, 524, 10.1016/j.micinf.2009.02.007 · DOI
  88. Garlanda, 2007, Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by Toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling, J Immunol, 179, 3119, 10.4049/jimmunol.179.5.3119 · DOI
  89. Wagenaar, 2009, Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis, PLoSNegl Trop Dis, 3, e453, 10.1371/journal.pntd.0000453 · DOI
  90. Becerra, 2008, Elevated levels of soluble ST2 protein in dengue virus infected patients, Cytokine, 41, 114, 10.1016/j.cyto.2007.11.001 · DOI
  91. Hudson, 2008, Induction of IL-33 expression and activity in central nervous system glia, J Leukoc Biol, 84, 631, 10.1189/jlb.1207830 · DOI
  92. Walzl, 2001, Inhibition of T1/ST 2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)-but not Th1-driven immunopathology, J Exp Med, 193, 785, 10.1084/jem.193.7.785 · DOI
  93. Kuchler, 2008, Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation, Am J Pathol, 173, 1229, 10.2353/ajpath.2008.080014 · DOI
  94. Choi, 2009, IL-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial NO production, Blood, 114, 3117, 10.1182/blood-2009-02-203372 · DOI
  95. Kuroiwa, 2000, Construction of ELISA system to quantify human ST2 protein in sera of patients, Hybridoma, 19, 151, 10.1089/02724570050031194 · DOI
  96. Oshikawa, 2001, Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation, Am J Respir Crit Care Med, 164, 277, 10.1164/ajrccm.164.2.2008120 · DOI
  97. Prefontaine, 2009, Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells, J Immunol, 183, 5094, 10.4049/jimmunol.0802387 · DOI · Paper page
  98. Gudbjartsson, 2009, Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction, Nat Genet, 41, 342, 10.1038/ng.323 · DOI · Paper page
  99. Reijmerink, 2008, Association of IL1RL1, IL18R1, and IL18RAP gene cluster polymorphisms with asthma and atopy, J Allergy Clin Immunol, 122, 651, 10.1016/j.jaci.2008.06.030 · DOI
  100. Ali, 2009, Investigations into the role of ST2 in acute asthma in children, Tissue Antigens, 73, 206, 10.1111/j.1399-0039.2008.01185.x · DOI
  101. Oshikawa, 2002, Expression and function of the ST2 gene in a murine model of allergic airway inflammation, Clin Exp Allergy, 32, 1520, 10.1046/j.1365-2745.2002.01494.x · DOI
  102. Hayakawa, 2007, Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation, J Biol Chem, 282, 26369, 10.1074/jbc.M704916200 · DOI
  103. Mangan, 2007, T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation, Eur J Immunol, 37, 1302, 10.1002/eji.200636520 · DOI
  104. Meisel, 2001, Regulation and function ofT1/ST2 expression on CD4+T cells: induction of type 2 cytokine production by T1/ST2 cross-linking, J Immunol, 166, 3143, 10.4049/jimmunol.166.5.3143 · DOI
  105. Coyle, 1999, Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses, J Exp Med, 190, 895, 10.1084/jem.190.7.895 · DOI
  106. Kearley, 2009, Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway, Am J Respir Crit Care Med, 179, 772, 10.1164/rccm.200805-666OC · DOI
  107. Liu, 2009, Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma, Biochem Biophys Res Commun, 386, 181, 10.1016/j.bbrc.2009.06.008 · DOI
  108. Cohn, 1997, Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production, J Exp Med, 186, 1737, 10.1084/jem.186.10.1737 · DOI
  109. Shimizu, 2005, Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis, Hum Mol Genet, 14, 2919, 10.1093/hmg/ddi323 · DOI
  110. Sakashita, 2008, Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis, Clin Exp Allergy, 38, 1875, 10.1111/j.1365-2222.2008.03114.x · DOI
  111. Castano, 2009, Evidence of association of interleukin-1 receptor-like 1 gene polymorphisms with chronic rhinosinusitis, Am J Rhinol Allergy, 23, 377, 10.2500/ajra.2009.23.3303 · DOI
  112. Hartmann, 2006, Gene expression profiling of skin and draining lymph nodes of rats affected with cutaneous contact hypersensitivity, Inflamm Res, 55, 322, 10.1007/s00011-006-5141-z · DOI
  113. Matsuda, 2009, The Role of interleukin-33 in chronic allergic conjunctivitis, Invest Ophthalmol Vis Sci, 50, 4646, 10.1167/iovs.08-3365 · DOI
  114. Fraser, 2006, Elevated soluble ST2 and cytokine levels in synovial fluids of patients with inflammatory synovitis, Ann Rheum Dis, 65, A10
  115. Xu, 2008, IL-33 exacerbates antigen-induced arthritis by activating mast cells, Proc Natl Acad Sci USA, 105, 10913, 10.1073/pnas.0801898105 · DOI
  116. Palmer, 2009, Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis, Arthritis Rheum, 60, 738, 10.1002/art.24305 · DOI
  117. Matsuyama, 2010, Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis, J Rheumatol, 37, 18, 10.3899/jrheum.090492 · DOI
  118. Leung, 2004, A novel therapy of murine collagen-induced arthritis with soluble T1/ST2, J Immunol, 173, 145, 10.4049/jimmunol.173.1.145 · DOI
  119. Tesch, 2007, Rodent models of streptozotocin-induced diabetic nephropathy, Nephrology (Carlton), 12, 261, 10.1111/j.1440-1797.2007.00796.x · DOI
  120. Lenzen, 2008, The mechanisms of alloxan- and streptozotocin-induced diabetes, Diabetologia, 51, 216, 10.1007/s00125-007-0886-7 · DOI
  121. Lamhamedi-Cherradi, 2003, Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/-mice, Nat Immunol, 4, 255, 10.1038/ni894 · DOI
  122. Pakala, 1999, In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha, J Exp Med, 189, 1053, 10.1084/jem.189.7.1053 · DOI
  123. Zdravkovic, 2009, Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin, Mol Immunol, 47, 28, 10.1016/j.molimm.2008.12.023 · DOI
  124. Miller, 2008, IL-33 reduces the development of atherosclerosis, J Exp Med, 205, 339, 10.1084/jem.20071868 · DOI
  125. Seidelin, 2010, IL-33 is upregulated in colonocytes of ulcerative colitis, Immunol Lett, 128, 80, 10.1016/j.imlet.2009.11.001 · DOI
  126. Axelsson, 1996, Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+)-cell depleted, athymic and NK-cell depleted SCID mice, Inflamm Res, 45, 181, 10.1007/BF02285159 · DOI
  127. Ueno, 2005, Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice, Inflamm Bowel Dis, 11, 35, 10.1097/00054725-200501000-00005 · DOI
  128. Minocha, 1995, Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice, Dig Dis Sci, 40, 1757, 10.1007/BF02212698 · DOI
  129. Xiao, 2007, The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis, Immunity, 26, 461, 10.1016/j.immuni.2007.02.012 · DOI
  130. Manetti, 2010, The IL-1-like cytokine IL-33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis, Ann Rheum Dis, 69, 598, 10.1136/ard.2009.119321 · DOI
  131. Rankin, 2010, IL-33 Induces IL-13-Dependent Cutaneous Fibrosis, J Immunol, 184, 1526, 10.4049/jimmunol.0903306 · DOI
  132. Kuroiwa, 2001, Identification of human ST2 protein in the sera of patients with autoimmune diseases, Biochem Biophys Res Commun, 284, 1104, 10.1006/bbrc.2001.5090 · DOI
  133. Mok, 2010, Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus, Rheumatology (Oxford), 49, 520, 10.1093/rheumatology/kep402 · DOI
  134. Lech, 2008, Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens, J Exp Med, 205, 1879, 10.1084/jem.20072646 · DOI
  135. Weinberg, 2003, Identification of serum soluble ST2 receptor as a novel heart failure biomarker, Circulation, 107, 721, 10.1161/01.CIR.0000047274.66749.FE · DOI
  136. Shimpo, 2004, Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction, Circulation, 109, 2186, 10.1161/01.CIR.0000127958.21003.5A · DOI
  137. Bartunek, 2008, Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load, J Am Coll Cardiol, 52, 2166, 10.1016/j.jacc.2008.09.027 · DOI
  138. Sanada, 2007, IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system, J Clin Invest, 117, 1538, 10.1172/JCI30634 · DOI
  139. Seki, 2009, Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling, Circ Heart Fail, 2, 684, 10.1161/CIRCHEARTFAILURE.109.873240 · DOI
  140. Marvie, 2009, Interleukin-33 overexpression is associated with liver fibrosis in mice and humans, J Cell Mol Med, 10.1111/j.1582-4934.2009.00801.x · DOI · Paper page
  141. Amatucci, 2007, Recombinant ST2 boosts hepatic Th2 response in vivo, J Leukoc Biol, 82, 124, 10.1189/jlb.1006625 · DOI
  142. Verri, 2004, Interleukin-18 induces mechanical hypernociception in rats via endothelin acting on ETB receptors in a morphine-sensitive manner, J Pharmacol Exp Ther, 310, 710, 10.1124/jpet.103.063990 · DOI
  143. White, 2008, IL-1beta signaling initiates inflammatory hypernociception, Brain Behav Immun, 22, 1014, 10.1016/j.bbi.2008.05.005 · DOI
  144. Verri, 2008, IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice, Proc Natl Acad Sci USA, 105, 2723, 10.1073/pnas.0712116105 · DOI

Cited by

Sorted by citations

See all 190

Metadata

Authors
Oboki, K., Ohno, T., Kajiwara, N., Saito, H., & Nakae, S.
Venue
Allergology International
Publisher
Japanese Society of Allergology
Published
2010
Volume
59
Issue
2
Pages
143-160
ISSN
1323-8930
DOI
10.2332/allergolint.10-rai-0186
Cited by
190
References
9
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IL-33 and IL-33 Receptors in Host Defense and Diseases. https://app.cochat.ai/papers/10.2332/allergolint.10-rai-0186
The paper
Oboki, K., Ohno, T., Kajiwara, N., Saito, H., & Nakae, S. (2010). IL-33 and IL-33 Receptors in Host Defense and Diseases. Allergology International. https://doi.org/10.2332/allergolint.10-rai-0186